27-hydroxycholesterol has been researched along with fingolimod hydrochloride in 1 studies
| Studies (27-hydroxycholesterol) | Trials (27-hydroxycholesterol) | Recent Studies (post-2010) (27-hydroxycholesterol) | Studies (fingolimod hydrochloride) | Trials (fingolimod hydrochloride) | Recent Studies (post-2010) (fingolimod hydrochloride) |
|---|---|---|---|---|---|
| 345 | 11 | 214 | 2,771 | 157 | 2,062 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bäck, N; Bittman, R; Blom, T; de Lera, A; Diczfalusy, U; Ikonen, E; Kovanen, PT; Li, Z; Mutka, AL | 1 |
1 other study(ies) available for 27-hydroxycholesterol and fingolimod hydrochloride
| Article | Year |
|---|---|
FTY720 stimulates 27-hydroxycholesterol production and confers atheroprotective effects in human primary macrophages.
Topics: Apolipoprotein A-I; Atherosclerosis; ATP Binding Cassette Transporter 1; ATP-Binding Cassette Transporters; Biological Transport; Carrier Proteins; Cell Culture Techniques; Cell Death; Cell Survival; Cells, Cultured; Cholesterol; Cholesterol Esters; Endoplasmic Reticulum; Endosomes; Fingolimod Hydrochloride; Humans; Hydroxycholesterols; Intracellular Signaling Peptides and Proteins; Lipoproteins, LDL; Liver X Receptors; Macrophages; Membrane Glycoproteins; Niemann-Pick C1 Protein; Orphan Nuclear Receptors; Propylene Glycols; Receptors, Scavenger; Signal Transduction; Sphingosine; Time Factors | 2010 |